Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Glucagon promotes net hepatic glycogen repletion following meal ingestion
Nidhi Kejriwal, David Bouslov, Cheyenne R. Castle, Riya S. Karve, Galina A. Arkharova, Ashot Sargsyan, Daniel J. Drucker, Guo-Fang Zhang, David A. D’Alessio, Jonathan E. Campbell, Megan E. Capozzi
Nidhi Kejriwal, David Bouslov, Cheyenne R. Castle, Riya S. Karve, Galina A. Arkharova, Ashot Sargsyan, Daniel J. Drucker, Guo-Fang Zhang, David A. D’Alessio, Jonathan E. Campbell, Megan E. Capozzi
View: Text | PDF
Research Article Endocrinology Metabolism

Glucagon promotes net hepatic glycogen repletion following meal ingestion

  • Text
  • PDF
Abstract

Insulin and glucagon are described as having opposing actions on hepatic glycogen metabolism. However, here we showed that their coordinated action promoted glycogen turnover and meal glucose storage. In mice, pharmacological doses of insulin or glucagon failed to alter hepatic glycogen, but the combination produced a robust decrease in glycogen content. Additivity between insulin and glucagon was also seen with the activation of hepatic insulin signaling intermediates. This signaling pathway drove glycogen synthesis, suggesting concurrent actions on glycogen breakdown and repletion. A mixed nutrient meal, which stimulates an increase in both insulin and glucagon, enhanced the incorporation of dietary glucose into hepatic glycogen. This was much more pronounced than the effects of glucose alone, which only stimulated insulin secretion. These findings revealed that glucagon is required for efficient hepatic glucose storage when acting in concert with insulin. Coordinated insulin-glucagon signaling, thus, emerged as a critical mechanism for hepatic glycogen cycling, challenging the classical paradigm that these hormones work in opposition.

Authors

Nidhi Kejriwal, David Bouslov, Cheyenne R. Castle, Riya S. Karve, Galina A. Arkharova, Ashot Sargsyan, Daniel J. Drucker, Guo-Fang Zhang, David A. D’Alessio, Jonathan E. Campbell, Megan E. Capozzi

×

Figure 1

Glucagon and insulin interact to decrease hepatic glycogen.

Options: View larger image (or click on image) Download as PowerPoint
Glucagon and insulin interact to decrease hepatic glycogen.
(A) Hepatic ...
(A) Hepatic glycogen content in WT mice under various feeding (black bars) and fasting (white bars) conditions. (B) Liver glycogen 30 minutes following i.p. injection of PBS or glucagon (1 mg/kg) in Control and Glp1r;Gcgrβcell–/– mice (n = 6–13 per group). (C) Plasma insulin levels at baseline and 10 minutes following 20 μg/kg glucagon or 1 mg/kg glucagon (n = 12 per group). (D) Liver glycogen 30 minutes after i.p. injection of PBS, insulin (1 U/kg), low-dose glucagon (20 μg/kg), high-dose glucagon (1 mg/kg), or insulin (1 U/kg) + low-dose glucagon (20 μg/kg) (n = 8–14 per group). (E) Glycogen in skeletal muscle 30 minutes after i.p. injection of PBS, insulin (1 U/kg), low-dose glucagon (20 μg/kg), high-dose glucagon (1 mg/kg), and insulin (1 U/kg) + low-dose glucagon (20 μg/kg). (F) Liver glycogen 30 minutes following i.p. injection of PBS or glucagon (1 mg/kg) in control and Gcgrhep–/– mice (n = 6–8 per group). (G) Liver glycogen 30 minutes following i.p. injection of PBS and insulin (1 U/kg) + low-dose glucagon (20 μg/kg) in Gcgrhep–/– mice (n = 4–5 per group). Data are shown as mean ± SEM. Two-way ANOVA (B, C, and F), 1-way ANOVA (D and E), or 2-tailed t-test (G) were used to determine significance, defined as P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts